Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03142724 · ClinicalTrials.gov registry record · Phase 1
Assessment of the Biodistribution and Safety of [18F]MNI-968 in Healthy Subjects
A Phase 1 study, sponsored by Molecular NeuroImaging.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT03142724 is a Phase 1 study that has completed, run by Molecular NeuroImaging. The registered enrollment target is 6 participants.
The verdict
NCT03142724, a Phase 1 study, has completed, sponsored by Molecular NeuroImaging.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The overall goal of this protocol is to evaluate the biodistribution of \[18F\]MNI-968 as a D1 receptor targeted radiopharmaceutical.
Interventions
- DRUG [18F]MNI-968
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2018-03-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03142724
The ClinicalTrials.gov registry entry for NCT03142724 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Molecular NeuroImaging, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which [18F]MNI-968 is the first listed.
NCT03142724 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03142724 about?
NCT03142724 is a clinical study titled "Assessment of the Biodistribution and Safety of [18F]MNI-968 in Healthy Subjects". The overall goal of this protocol is to evaluate the biodistribution of \[18F\]MNI-968 as a D1 receptor targeted radiopharmaceutical.
What is the current status of trial NCT03142724?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2017-05-01. Estimated completion is 2018-03-01.
What interventions are being tested in trial NCT03142724?
The interventions under investigation include: [18F]MNI-968 (DRUG).
Who is sponsoring clinical trial NCT03142724?
This trial is sponsored by Molecular NeuroImaging, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.